[go: up one dir, main page]

WO2003017048A3 - A method of screening for disorders of glucose metabolism - Google Patents

A method of screening for disorders of glucose metabolism Download PDF

Info

Publication number
WO2003017048A3
WO2003017048A3 PCT/US2002/025764 US0225764W WO03017048A3 WO 2003017048 A3 WO2003017048 A3 WO 2003017048A3 US 0225764 W US0225764 W US 0225764W WO 03017048 A3 WO03017048 A3 WO 03017048A3
Authority
WO
WIPO (PCT)
Prior art keywords
glucose
disorders
screening
subject
profile
Prior art date
Application number
PCT/US2002/025764
Other languages
French (fr)
Other versions
WO2003017048A2 (en
Inventor
Stephen L Monfre
Linda Hockersmith
Donald Hetzel
Kevin Hazen
Andrew Cone
Original Assignee
Sensys Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sensys Medical Inc filed Critical Sensys Medical Inc
Priority to AU2002356044A priority Critical patent/AU2002356044A1/en
Publication of WO2003017048A2 publication Critical patent/WO2003017048A2/en
Publication of WO2003017048A3 publication Critical patent/WO2003017048A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Fuzzy Systems (AREA)
  • Evolutionary Computation (AREA)
  • Pathology (AREA)
  • Mathematical Physics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method of screening for disorders of glucose metabolism such as impaired glucose tolerance and diabetes allows prevention, or early detection and treatment of diabetic complications such as cardiovascular disease, retinopathy, and other disorders of the major organs and systems. A mathematical algorithm evaluates the shape of a subject's glucose profile and classifies the profile into one of several predefined clusters, each cluster corresponding either to a normal condition or one of several abnormal conditions. The series of blood glucose values making up the glucose tolerance curve may be measured using any glucose analyzer including: invasive, minimally invasive and noninvasive types. The method is executed on a processing device programmed to perform the steps of the method. Depending on the outcome of the screening, a subject may be provided with additional information concerning their condition and/or counseled to consult further with their health care provider.
PCT/US2002/025764 2001-08-13 2002-08-13 A method of screening for disorders of glucose metabolism WO2003017048A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002356044A AU2002356044A1 (en) 2001-08-13 2002-08-13 A method of screening for disorders of glucose metabolism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31215501P 2001-08-13 2001-08-13
US60/312,155 2001-08-13

Publications (2)

Publication Number Publication Date
WO2003017048A2 WO2003017048A2 (en) 2003-02-27
WO2003017048A3 true WO2003017048A3 (en) 2003-05-30

Family

ID=23210119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/025764 WO2003017048A2 (en) 2001-08-13 2002-08-13 A method of screening for disorders of glucose metabolism

Country Status (2)

Country Link
AU (1) AU2002356044A1 (en)
WO (1) WO2003017048A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020042143A1 (en) * 1998-05-06 2002-04-11 Yatscoff Randall W. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020042143A1 (en) * 1998-05-06 2002-04-11 Yatscoff Randall W. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Is fasting glucose sufficient to defined diabetes? epidemiological data from 20 european studies", DIABETOLOGIA (STENO DIABETES CENTRE), vol. 42, 1999, pages 647 - 654, XP002961909 *
DATABASE WPI Week 199715, Derwent World Patents Index; AN 1990-084737, XP002961908, ALBRECHT ET AL. *

Also Published As

Publication number Publication date
AU2002356044A1 (en) 2003-03-03
WO2003017048A2 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
WO2004043230A3 (en) A method of screening for disorders of glucose metabolism
Klonoff A review of continuous glucose monitoring technology
Watts Behavioural aspects of the management of diabetes mellitus: education, self-care and metabolic control
Dahle et al. Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults.
US20040225205A1 (en) Glucose level control method and system
US20020133063A1 (en) Use of targeted glycemic profiles in the calibration of a noninvasive blood glucose monitor
Janicki et al. Long-term reproducibility of respiratory gas exchange measurements during exercise in patients with stable cardiac failure
US20160345842A1 (en) Metabolic monitoring, a method and apparatus for indicating a health-related condition of a subject
WO2004088304A3 (en) Method and device for utilizing analyte levels to assist in the treatment of diabetes, insulin resistance and metabolic syndrome
US20080114212A1 (en) Detecting surgical phases and/or interventions
WO2003060808A3 (en) Systems and methods for medication monitoring
DE102007046295A1 (en) Methods and apparatus for the continuous and mobile measurement of various vital parameters in the external auditory canal, in particular measurement of the ECG, the body (core) temperature, tissue-optical parameters
Temple et al. Association of habitual daily physical activity with glucose tolerance and β-cell function in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes from the restoring insulin secretion (RISE) study
EP1922989A2 (en) Method and device for the continuous mobile measuring of different vital signs in the outer auditory canal
US11992310B2 (en) Personal health monitoring system, multiple user health monitoring system, and method
WO2003017048A3 (en) A method of screening for disorders of glucose metabolism
Parati et al. Daily-life baroreflex modulation: new perspectives from computer analysis of blood pressure and heart rate variability
Ríos et al. An automatic apnea screening algorithm for children
Garner et al. Complexity of cardiac autonomic modulation in diabetes mellitus: A new technique to perceive autonomic dysfunction
Colton et al. Preventing eating disorders in young women with diabetes
Góra Morbidity of children and adolescents with selected chronic diseases in Poland, 2017–2022
Byrne et al. Continuous glucose monitoring: is it helpful in pregnancy?
Zhu et al. A14723 Comparison of arterial stiffness indices measured by pulse wave velocity and pulse wave analysis in a Chinese population
CN120514329A (en) Anesthesia depth monitoring system and method based on multiple physiological parameters
Chua et al. A17183 Micronutrient Intake Adequacy and Hypertension Risk among Rural-Dwelling Indigenous Adults in Peninsular Malaysia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR CA CH CN CR CU CZ DE DK DM EE ES GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU MA MD MG MK MN MW MX NO NZ PT RO RU SD SE SG SI SK SL TJ TM TT TZ UA UG UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP